China-linked DKnife framework uses router-level AitM implants for traffic hijacking, credential theft, and malware delivery targeting edge devices.
Phase 3 trial data show datopotamab deruxtecan reduces the risk of disease progression or death in patients with metastatic TNBC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results